- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
NANOFH
HEL
Week ended 07 Aug 2026
Weekly Investor Report
Nanoform Finland Oyj · Healthcare · Biotechnology
Latest close
0.99 EUR
14.7%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 29.4% above the Trend Line and sits at 61.0% of its 52-week range. The latest completed week returned 14.7%, after a 29.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
45
out of 100
Latest Close
0.99 EUR
7 Aug 2026
1W Return
14.7%
latest completed week
4W Return
29.4%
short-term follow-through
12W Return
7.8%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 34.36% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
14.7%
Latest completed week; four-week move 29.4%.
Indicator stack
22/66
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 34.36%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 29.4% above the Trend Line and sits at 61.0% of its 52-week range. The latest completed week returned 14.7%, after a 29.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3712-week average 0.23
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.37Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 29.4% over four weeks, 7.8% over 12 weeks, and 1.9% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.62Latest activity-pressure read.
Pressure change55.6%Four-week change in activity pressure.
Leadership3.18Latest relative-leadership reading.
RS change114.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
1 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-28.4%Distance below the 52-week high.
13-week volatility15.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+49.5%Week of 15 May.
Worst week-29.3%Week of 3 Apr.
Latest week+14.7%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains5
Flat weeks0
Modest losses2
Sharp losses11
Recent vol15.4%13-week weekly-return volatility.
Base vol12.7%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew11.2% / -7.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFI Healthcare
4-week rank1 / 16
Group average1.5%
Trend breadth18.8%
Trend18.8%active weekly trend signals
MD68.8%positive activity pressure
RS18.8%positive relative leadership
Four-week leaders
IndustryFI Biotechnology
4-week rank1 / 3
Group average6.4%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD66.7%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape38/100
Trend, activity pressure, participation, and risk combine to a 38/100 tape read.
Indicator analysis42/100Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 1/12.
Activity pressure 0.37; No reversal markers Next-Week ExpectancyNegative 34.36%Next-week expectancy is negative with a 34.36% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
Nanoform Finland Oyj : Invitation to Nanoform's Q2 2026 Report Presentation Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.99 EUR | 14.7% | 0.77 EUR | 1.38 EUR | 0.62 | 3.18 | 622.5K | On |
| 31 Jul 2026 | 0.86 EUR | 0.8% | 0.77 EUR | 1.39 EUR | 0.46 | -10.23 | 281.1K | On |
| 24 Jul 2026 | 0.86 EUR | 5.4% | 0.78 EUR | 1.40 EUR | 0.39 | -11.59 | 267.2K | Off |
| 17 Jul 2026 | 0.81 EUR | 6.1% | 0.79 EUR | 1.40 EUR | 0.36 | -16.55 | 143.6K | Off |
| 10 Jul 2026 | 0.77 EUR | -0.5% | 0.80 EUR | 1.41 EUR | 0.40 | -22.12 | 163.2K | Off |
| 3 Jul 2026 | 0.77 EUR | -3.0% | 0.81 EUR | 1.41 EUR | 0.43 | -23.85 | 67.4K | Off |
| 26 Jun 2026 | 0.79 EUR | -7.7% | 0.81 EUR | 1.42 EUR | 0.55 | -20.86 | 159.9K | Off |
| 19 Jun 2026 | 0.86 EUR | 0.9% | 0.82 EUR | 1.43 EUR | 0.73 | -16.31 | 264.3K | Off |
| 12 Jun 2026 | 0.85 EUR | -12.4% | 0.82 EUR | 1.44 EUR | 0.83 | -19.42 | 148.2K | Off |
| 5 Jun 2026 | 0.97 EUR | -6.1% | 0.83 EUR | 1.45 EUR | 1.00 | -10.45 | 100.0K | Off |
| 29 May 2026 | 1.03 EUR | 18.7% | 0.83 EUR | 1.45 EUR | 0.72 | -4.88 | 1.4M | Off |
| 22 May 2026 | 0.87 EUR | -5.1% | 0.84 EUR | 1.46 EUR | 0.11 | -20.42 | 1.5M | Off |
| 15 May 2026 | 0.92 EUR | 49.5% | 0.85 EUR | 1.47 EUR | -0.47 | -13.94 | 3.3M | Off |
| 8 May 2026 | 0.61 EUR | 23.5% | 0.85 EUR | 1.48 EUR | -1.05 | -42.48 | 1.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.